Carvedilol NDC 71335-2023

Product information

Brand name (proprietary)

Carvedilol

Generic name (nonproprietary)

carvedilol

Active ingredients

Carvedilol — 25 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Bryant Ranch Prepack

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 078165

Marketing start

Jul 29, 2021

Listing expires

Dec 31, 2027

Other FDA classes

Adrenergic alpha-Antagonists (Mechanism)Adrenergic beta1-Antagonists (Mechanism)Adrenergic beta2-Antagonists (Mechanism)

Identifiers

Product ID 71335-2023_6f8dec1e-7fea-454b-99c7-4e3543647336SPL ID 6f8dec1e-7fea-454b-99c7-4e3543647336SPL set ID 1ddff189-1848-4186-bca9-063e4ea7fd1fRxCUI 200033UNII 0K47UL67F2

Pharmacologic class

alpha-Adrenergic Blocker; beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335202301 followed by a unit qualifier and the quantity Copy

Package 71335-2023-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 078165

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.